MAPT and Alzheimer disease: In batch-processed neocortical sections from AD cases, neuronal and plaque-like profiles were labeled by the C-terminal sortilin antibody (Fig. 3j, k), with aberrant Aβ (Fig. 3l, m) and p-tau (Fig. 3n, o) immunoreactivity confirmed in neighboring sections.